4.7 Article

Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level

Journal

DIABETOLOGIA
Volume 57, Issue 4, Pages 785-796

Publisher

SPRINGER
DOI: 10.1007/s00125-013-3154-z

Keywords

Gluconeogenesis; HNF4 alpha; Liver; TCF7L2 isoforms

Funding

  1. French National Research Agency
  2. Medical Research Council [G1002084] Funding Source: researchfish
  3. MRC [G1002084] Funding Source: UKRI

Ask authors/readers for more resources

Aims/hypothesis Gene polymorphisms of TCF7L2 are associated with increased risk of type 2 diabetes and transcription factor 7-like 2 (TCF7L2) plays a role in hepatic glucose metabolism. We therefore addressed the impact of TCF7L2 isoforms on hepatocyte nuclear factor 4 alpha (HNF4 alpha) and the regulation of gluconeogenesis genes. Methods Liver TCF7L2 transcripts were analysed by quantitative PCR in 33 non-diabetic and 31 type 2 diabetic obese individuals genotyped for TCF7L2 rs7903146. To analyse transcriptional regulation by TCF7L2, small interfering RNA transfection, luciferase reporter and co-immunoprecipitation assays were performed in human hepatoma HepG2 cells. Results In livers of diabetic compared with normoglycaemic individuals, five C-terminal TCF7L2 transcripts showed increased expression. The type 2 diabetes risk allele of rs7903146 positively correlated with TCF7L2 expression in livers from normoglycaemic individuals only. In HepG2 cells, transcript and TCF7L2 protein levels were increased upon incubation in high glucose and insulin. Of the exon 13 transcripts, six were increased in a glucose dose-responsive manner. TCF7L2 transcriptionally regulated 29 genes related to glucose metabolism, including glucose-6-phosphatase. In cultured HepG2 cells, TCF7L2 did not regulate HNF4I and FOXO1 transcription, but did affect HNF4 alpha protein expression. The TCF7L2 isoforms T6 and T8 (without exon 13 and with exon 15/14, respectively) specifically interacted with HNF4 alpha. Conclusions/interpretation The different levels of expression of alternative C-terminal TCF7L2 transcripts in HepG2 cells, in livers of normoglycaemic individuals carrying the rs7901346 type 2 diabetes risk allele and in livers of diabetic individuals suggest that these transcripts play a role in the pathophysiology of type 2 diabetes. We also report for the first time a protein interaction in HepG2 cells between HNF4 alpha and the T6 and T8 isoforms of TCF7L2, which suggests a distinct role for these specific alternative transcripts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Rare Variant Analysis of Obesity-Associated Genes in Young Adults With Severe Obesity From a Consanguineous Population of Pakistan

Sadia Saeed, Qasim M. Janjua, Attiya Haseeb, Roohia Khanam, Emmanuelle Durand, Emmanuel Vaillant, Lijiao Ning, Alaa Badreddine, Lionel Berberian, Mathilde Boissel, Souhila Amanzougarene, Mickael Canouil, Mehdi Derhourhi, Amelie Bonnefond, Muhammad Arslan, Philippe Froguel

Summary: Recent advances in genetic analysis have helped understand the genetic basis of obesity, specifically the disruption of melanocortin signaling by monogenic variants. In this study, rare variants in obesity-causing genes were assessed in young adults with severe obesity from Pakistan. Thirteen subjects were found to carry pathogenic variants in different obesity-related genes, including two homozygous stop-gain mutations in previously unreported genes. Homozygous mutations and copy-loss CNVs in genes previously linked to obesity were also identified. Notably, pathogenic mutations in LEP and LEPR were rarely found in this cohort of young adults, possibly due to differences in morbidity and social disadvantage compared to obese children.

DIABETES (2022)

Article Endocrinology & Metabolism

Maternal Glycemic Dysregulation During Pregnancy and Neonatal Blood DNA Methylation: Meta-analyses of Epigenome-Wide Association Studies

Elmar W. Tobi, Diana L. Juvinao-Quintero, Justiina Ronkainen, Raffael Ott, Rossella Alfano, Mickael Canouil, Madelon L. Geurtsen, Amna Khamis, Leanne K. Kupers, Ives Y. Lim, Patrice Perron, Giancarlo Pesce, Johanna Tuhkanen, Anne P. Starling, Toby Andrew, Elisabeth Binder, Robert Caiazzo, Jerry K. Y. Chan, Romy Gaillard, Peter D. Gluckman, Elina Keikkala, Neerja Karnani, Sanna Mustaniemi, Tim S. Nawrot, Francois Pattou, Michelle Plusquin, Violeta Raverdy, Kok Hian Tan, Evangelia Tzala, Katri Raikkonen, Christiane Winkler, Anette-G Ziegler, Isabella Annesi-Maesano, Luigi Bouchard, Yap Seng Chong, Dana Dabelea, Janine F. Felix, Barbara Heude, Vincent W. V. Jaddoe, Jari Lahti, Brigitte Reimann, Marja Vaarasmaki, Amelie Bonnefond, Philippe Froguel, Sandra Hummel, Eero Kajantie, Marjo-Riita Jarvelin, Regine P. M. Steegers-Theunissen, Caitlin G. Howe, Marie-France Hivert, Sylvain Sebert

Summary: Maternal hyperglycemia is associated with lower cord blood DNAm at TXNIP, and these CpGs may be candidate loci for future causal and mediation analyses.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia

Prapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, Amelie Bonnefond, Serena Pezzilli, Tommaso Biagini, Patinut Buranasupkajorn, Timothy Hastings, Christine Mendonca, Lorella Marselli, Rosa Di Paola, Zuroida Abubakar, Luana Mercuri, Federica Alberico, Elisabetta Flex, Julian Ceron, Montserrat Porta-de-la-Riva, Ornella Ludovico, Massimo Carella, Simone Martinelli, Piero Marchetti, Tommaso Mazza, Philippe Froguel, Vincenzo Trischitta, Alessandro Doria, Sabrina Prudente

Summary: This study identified mutations in the MDH2 gene that are associated with familial forms of diabetes. These mutations affect the structure and function of the MDH2 protein. They increase the enzymatic activity of MDH2, leading to a decrease in the NAD+/NADH ratio and affecting insulin signaling and secretion. This study suggests that gain of function variants in the MDH2 gene may play a role in the etiology of familial forms of diabetes.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Chemistry, Physical

Innovative transdermal delivery of insulin using gelatin methacrylate-based microneedle patches in mice and mini-pigs

Bilal Demir, Lea Rosselle, Anna Voronova, Quentin Pagneux, Audrey Quenon, Valery Gmyr, Dorothee Jary, Nathalie Hennuyer, Bart Staels, Thomas Hubert, Amar Abderrahmani, Valerie Plaisance, Valerie Pawlowski, Rabah Boukherroub, Severine Vignoud, Sabine Szunerits

Summary: Through engineering non-dissolving microneedle arrays and incorporating MoS2 nanosheets as a photothermal component into hydrogels, on-demand release of macromolecular therapeutic drugs such as insulin has been achieved for skin penetration and therapeutic purposes. This system successfully reduced blood glucose levels in mice and pigs, potentially altering current insulin therapies.

NANOSCALE HORIZONS (2022)

Article Multidisciplinary Sciences

Enterocyte superoxide dismutase 2 deletion drives obesity

Oihane Garcia-Irigoyen, Fabiola Bovenga, Marilidia Piglionica, Elena Piccinin, Marica Cariello, Maria Arconzo, Claudia Peres, Paola Antonia Corsetto, Angela Maria Rizzo, Marta Ballanti, Rossella Menghini, Geltrude Mingrone, Philippe Lefebvre, Bart Staels, Takuji Shirasawa, Carlo Sabba, Gaetano Villani, Massimo Federici, Antonio Moschetta

Summary: This study provides compelling evidence supporting the involvement of oxidative stress and intestinal inflammation in obesity and its related comorbidities. The deficiency of the antioxidant enzyme SOD2 in the gastrointestinal tract leads to spontaneous obesity in mice. This obesity phenotype is driven by PLA2 activation and increased release of arachidonic acid. The negative correlation between intestinal SOD2 mRNA levels and obesity features is conserved between mice and humans, suggesting potential therapeutic targets for this metabolic disorder.

ISCIENCE (2022)

Review Biochemistry & Molecular Biology

Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement

Fanny Lassalle, Mickael Rosa, Bart Staels, Eric Van Belle, Sophie Susen, Annabelle Dupont

Summary: Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic valve stenosis (AVS) and is considered an alternative to open heart surgery. TAVR has shown good prognosis for patients, but is still associated with postprocedural complications like bleeding or thrombosis. This study aimed to provide a comprehensive overview of the impact of TAVR on monocyte phenotype and subset distribution and their association with clinical outcomes in patients with severe AVS who underwent TAVR.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Endocrinology & Metabolism

Inhibition of the endocannabinoid system reverses obese phenotype in aged mice and partly restores skeletal muscle function

Lucas Fajardo, Phelipe Sanchez, Jerome Salles, Jean Paul Rigaudiere, Veronique Patrac, Sylvie Caspar-Bauguil, Camille Bergoglgio, Cedric Moro, Stephane Walrand, Olivier Le Bacquer

Summary: Inhibition of the endocannabinoid system (ECS) by RIM (10 mg/kg/day) was effective in reducing body fat and improving muscle function in obese aged mice.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Article Nutrition & Dietetics

An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery

Marion Courtalin, Helene Verkindt, Naima Oukhouya Daoud, Nassima Ramdane, Bernard Cortet, Francois Pattou, Julien Paccou

Summary: The study aimed to evaluate the implementation of the ECTS 2022 recommendations for preventing and treating osteoporosis after bariatric surgery. A retrospective cohort study was conducted on postmenopausal women and men aged 50 and older who had undergone or were undergoing bariatric surgery. Osteoporosis medication was indicated if certain criteria were met, and a fifth of the population surveyed was found to be eligible.

NUTRIENTS (2023)

Article Medicine, General & Internal

Monogenic diabetes

Amelie Bonnefond, Ranjit Unnikrishnan, Alessandro Doria, Martine Vaxillaire, Rohit N. Kulkarni, Viswanathan Mohan, Vincenzo Trischitta, Philippe Froguel

Summary: Monogenic diabetes encompasses several clinical conditions characterized by early-onset diabetes, including neonatal diabetes, maturity-onset diabetes of the young (MODY) and diabetes-associated syndromes. It can be misdiagnosed as type 2 diabetes, and different genetic variations can lead to different forms of diabetes. Precision medicine approaches and next-generation sequencing have improved diagnosis and treatment options.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Cell Biology

High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry

Clement Philippe Delannoy, Egon Heuson, Adrien Herledan, Frederik Oger, Bryan Thiroux, Mickael Chevalier, Xavier Gromada, Laure Rolland, Philippe Froguel, Benoit Deprez, Sebastien Paul, Jean-Sebastien Annicotte

Summary: Type 2 diabetes is a metabolic disorder affecting over 537 million people worldwide, characterized by loss of pancreatic beta-cell function and insulin resistance. Long-term control of glycemia is challenging, highlighting the need for new drugs and targets to improve beta-cell function and insulin secretion. In this study, a high-throughput screening method using automated cellular assays and mass spectrometry was developed, identifying potential regulators of insulin secretion and synthesis among siRNA and chemical compounds.

CELLS (2023)

Article Cell Biology

Knocking Down CDKN2A in 3D hiPSC-Derived Brown Adipose Progenitors Potentiates Differentiation, Oxidative Metabolism and Browning Process

Yasmina Kahoul, Xi Yao, Frederik Oger, Maeva Moreno, Souhila Amanzougarene, Mehdi Derhourhi, Emmanuelle Durand, Raphael Boutry, Amelie Bonnefond, Philippe Froguel, Christian Dani, Jean-Sebastien Annicotte, Christophe Breton

Summary: Human induced pluripotent stem cells (hiPSCs) have the potential to differentiate into any cell type, making them relevant for therapeutic applications. In particular, they hold promise for obesity treatment by providing an unlimited source of brown/beige adipose progenitors (hiPSC-BAPs). However, the limited differentiation potential of brown/beige adipocytes in 2D cultures poses a challenge for clinical use.

CELLS (2023)

Article Endocrinology & Metabolism

Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study

Lise Folon, Morgane Baron, Benedicte Toussaint, Emmanuel Vaillant, Mathilde Boissel, Victoria Scherrer, Helene Loiselle, Audrey Leloire, Alaa Badreddine, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Soulaimane Aboulouard, Michel Salzet, Mickael Canouil, Mehdi Derhourhi, Philippe Froguel, Amelie Bonnefond

Summary: Rare biallelic pathogenic mutations in PCSK1 cause early-onset obesity and other endocrinopathies. Functional genomic study shows that rare heterozygous variants of PCSK1 can also impact obesity risk.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Meeting Abstract Endocrinology & Metabolism

Natural History of LEP, LEPR and MC4R Deficiencies - A Population-Based Study

Sadia Saeed, Jaida Manzoor, Roohia Khanam, Qasim Janjua, Lijiao Ning, Hina Ayesha, Waqas Khan, Amelie Bonnefond, Sharoon Hanook, Taeed Butt, Muhammad Arslan, Philippe Froguel

HORMONE RESEARCH IN PAEDIATRICS (2022)

Meeting Abstract Genetics & Heredity

Multi-phenotype GWAS Uncovers Shared Genetic Loci between Type 2 Diabetes, BMI, Colorectal, Pancreatic, Breast and Prostate Cancers

Igor Pupko, Ayse Demirkan, Liudmila Zudina, Zhanna Balkhiyarova, Anna Ulrich, Vincent Pascat, Jared Maina, Philippe Froguel, Marika Kaakinen, Inga Prokopenko

GENETIC EPIDEMIOLOGY (2022)

Meeting Abstract Endocrinology & Metabolism

The impact of rare pathogenic variants of GLIS3 on type 2 diabetes

S. Meulebrouck, M. Canouil, M. Derhourhi, B. Balkau, G. Charpentier, S. Franc, M. Michel, R. Roussel, M. Vaxillaire, P. Froguel, A. Bonnefond

DIABETOLOGIA (2022)

No Data Available